Go Pro

David Larsen Analyst Performance

Analyst at JPMorgan Chase & Co.

David Larsen is a stock analyst at JPMorgan Chase & Co. focused in the healthcare sector, covering 30 publicly traded companies. Over the past year, David Larsen has issued 72 stock ratings, including buy and hold recommendations. While full access to David Larsen's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Larsen's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
151 Last 11 Years
Buy Recommendations
76.35% 113 Buy Ratings
Companies Covered
30 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy76.4%113 ratings
Hold23.6%35 ratings
Sell0.0%0 ratings

Out of 148 total stock ratings issued by David Larsen at JPMorgan Chase & Co., the majority (76.4%) have been Buy recommendations, followed by 23.6% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
63.3% of companies on NASDAQ
19 companies
NYSE
33.3% of companies on NYSE
10 companies
OTCMKTS
3.3% of companies on OTCMKTS
1 company

David Larsen, an analyst at JPMorgan Chase & Co., currently covers 30 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
28 companies
93.3%
Technology
1 company
3.3%
Miscellaneous
1 company
3.3%

David Larsen of JPMorgan Chase & Co. specializes in stock coverage within the Healthcare sector, with additional focus on Technology and companies.

Coverage Industries

IndustryPercentage
HEALTHCARE PROVIDERS & SERVICES
19 companies
63.3%
HEALTHCARE TECHNOLOGY
5 companies
16.7%
HEALTHCARE EQUIPMENT & SUPPLIES
2 companies
6.7%
LIFE SCIENCES TOOLS & SERVICES
2 companies
6.7%
SOFTWARE
1 company
3.3%
Miscellaneous
1 company
3.3%

David Larsen's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Henry Schein, Inc. stock logo
HSIC
Henry Schein
8/19/2026Boost Price Target$89.23$110.00Buy
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
8/19/2026Boost Price Target$12.36$18.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
8/13/2026Reiterated Rating$59.68$90.00Buy
Omada Health, Inc. stock logo
OMDA
Omada Health
8/10/2026Boost Price Target$23.67$35.00Buy
Consensus Cloud Solutions, Inc. stock logo
CCSI
Consensus Cloud Solutions
8/10/2026Boost Price Target$35.14$50.00Buy
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
8/7/2026Boost Price Target$10.66$16.00Buy
LifeMD, Inc. stock logo
LFMD
LifeMD
8/6/2026Lower Price Target$3.68$9.00Buy
Henry Schein, Inc. stock logo
HSIC
Henry Schein
8/5/2026Reiterated Rating$89.11$100.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
8/3/2026Reiterated Rating$59.71$90.00Buy
Medline stock logo
MDLN
Medline
7/31/2026Reiterated Rating$39.12$55.00Buy
CryoPort, Inc. stock logo
CYRX
CryoPort
7/24/2026Boost Price Target$16.03$25.00Buy
Consensus Cloud Solutions, Inc. stock logo
CCSI
Consensus Cloud Solutions
7/24/2026Boost Price Target$34.55$45.00Buy
HealthEquity, Inc. stock logo
HQY
HealthEquity
7/24/2026Boost Price Target$94.33$115.00Buy
Progyny, Inc. stock logo
PGNY
Progyny
7/24/2026Boost Price Target$30.70$40.00Buy
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
7/24/2026Boost Price Target$10.81$15.00Buy
Omada Health, Inc. stock logo
OMDA
Omada Health
7/17/2026Initiated Coverage$23.67$30.00Buy
Omada Health, Inc. stock logo
OMDA
Omada Health
7/17/2026Initiated Coverage$23.70$30.00Buy
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
7/9/2026Boost Price Target$5.85$9.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
6/22/2026Boost Price Target$66.25$90.00Buy
Henry Schein, Inc. stock logo
HSIC
Henry Schein
6/11/2026Upgrade$78.85$100.00Buy
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
6/8/2026Boost Price Target$4.87$8.00Buy
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
6/4/2026Reiterated Rating$178.69$340.00Buy
Astrana Health, Inc. stock logo
ASTH
Astrana Health
6/2/2026Reiterated Rating$37.76$50.00Buy
Doximity, Inc. stock logo
DOCS
Doximity
5/14/2026Downgrade$23.52Neutral
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
5/12/2026Reiterated Rating$29.12Neutral
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
5/8/2026Boost Price Target$8.85$12.00Buy
Astrana Health, Inc. stock logo
ASTH
Astrana Health
5/8/2026Boost Price Target$36.08$50.00Buy
Medline stock logo
MDLN
Medline
5/7/2026Reiterated Rating$42.01$55.00Buy
CryoPort, Inc. stock logo
CYRX
CryoPort
5/5/2026Boost Price Target$10.21$17.00Buy
LifeMD, Inc. stock logo
LFMD
LifeMD
5/4/2026Reiterated Rating$5.00$10.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
5/4/2026Boost Price Target$52.58$65.00Buy
Henry Schein, Inc. stock logo
HSIC
Henry Schein
4/16/2026Initiated Coverage$77.42Neutral
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
3/19/2026Reiterated Rating$43.07$55.00Buy
LifeMD, Inc. stock logo
LFMD
LifeMD
3/10/2026Reiterated Rating$3.12$10.00Buy
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
3/9/2026Reiterated Rating$2.78$7.00Buy
Medline stock logo
MDLN
Medline
3/9/2026Reiterated Rating$43.83$55.00Buy
Progyny, Inc. stock logo
PGNY
Progyny
3/5/2026Lower Price Target$17.62$30.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
3/2/2026Reiterated Rating$41.43$55.00Buy
Evolent Health, Inc stock logo
EVH
Evolent Health
2/25/2026Lower Price Target$2.56$8.00Buy
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2/24/2026Downgrade$15.47Neutral
These gold assets are priced for $1,800 gold [it's over $4,000] (Ad)

Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.tc pixel

See the junior gold assets majors may target next
HealthEquity, Inc. stock logo
HQY
HealthEquity
2/17/2026Lower Price Target$73.88$110.00Buy
Consensus Cloud Solutions, Inc. stock logo
CCSI
Consensus Cloud Solutions
2/17/2026Boost Price Target$29.61$40.00Buy
Doximity, Inc. stock logo
DOCS
Doximity
2/6/2026Lower Price Target$33.30$50.00Buy
Evolent Health, Inc stock logo
EVH
Evolent Health
2/2/2026Lower Price Target$3.21$10.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
2/2/2026Boost Price Target$39.27$55.00Buy
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
2/2/2026Boost Price Target$7.07$11.00Buy
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2/2/2026Lower Price Target$27.15$60.00Buy
Astrana Health, Inc. stock logo
ASTH
Astrana Health
2/2/2026Lower Price Target$22.74$40.00Buy
Medline stock logo
MDLN
Medline
1/21/2026Reiterated Rating$44.15$55.00Buy
Medline stock logo
MDLN
Medline
1/21/2026Set Price Target$43.23$55.00
Medline stock logo
MDLN
Medline
1/12/2026Initiated Coverage$40.52$50.00Buy
Medline stock logo
MDLN
Medline
1/12/2026Initiated Coverage$42.72$50.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
12/23/2025Boost Price Target$38.00$50.00Buy
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
12/18/2025Downgrade$18.70Neutral
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
12/12/2025Boost Price Target$6.76$10.00Buy
P3 Health Partners Inc. stock logo
PIII
P3 Health Partners
12/12/2025Reiterated Rating$5.11Neutral
Agilon Health, Inc. stock logo
AGL
Agilon Health
12/12/2025Reiterated Rating$0.72Neutral
HealthEquity, Inc. stock logo
HQY
HealthEquity
12/4/2025Reiterated Rating$98.64$130.00Buy
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
11/21/2025Reiterated Rating$271.01$340.00Buy
LifeMD, Inc. stock logo
LFMD
LifeMD
11/18/2025Lower Price Target$4.73$10.00Buy
Evolent Health, Inc stock logo
EVH
Evolent Health
11/7/2025Lower Price Target$5.16$16.00Buy
Astrana Health, Inc. stock logo
ASTH
Astrana Health
11/7/2025Lower Price Target$26.76$45.00Buy
LifeStance Health Group, Inc. stock logo
LFST
LifeStance Health Group
11/6/2025Boost Price Target$6.25$9.00Buy
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11/4/2025Reiterated Rating$44.34$85.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
10/29/2025Boost Price Target$34.00$41.00Buy
The Oncology Institute, Inc. stock logo
TOI
Oncology Institute
10/21/2025Reiterated Rating$4.24$7.00Buy
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
10/17/2025Reiterated Rating$292.71$340.00Buy
Evolent Health, Inc stock logo
EVH
Evolent Health
9/30/2025Reiterated Rating$8.75$20.00Buy
CryoPort, Inc. stock logo
CYRX
CryoPort
9/18/2025Boost Price Target$8.87$15.00Buy
Evolent Health, Inc stock logo
EVH
Evolent Health
9/9/2025Reiterated Rating$9.66$20.00Buy
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
9/5/2025Reiterated Rating$3.30Neutral
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
8/28/2025Boost Price Target$276.66$340.00Buy
Simulations Plus, Inc. stock logo
SLP
Simulations Plus
7/7/2025Lower Price Target$16.83$25.00Buy
CryoPort, Inc. stock logo
CYRX
CryoPort
7/7/2025Lower Price Target$7.29$10.00Buy
Doximity, Inc. stock logo
DOCS
Doximity
6/2/2025Upgrade$52.22$80.00Buy
Progyny, Inc. stock logo
PGNY
Progyny
3/31/2025Upgrade$22.51$28.00Buy